IC-CS Risk: Patient Outcomes

September 2, 2025 updated by: Rebecca Feldman Hamm, University of Pennsylvania

Implementation of Calculated Cesarean Section Risk Study: Patient-focused Outcomes

This study is looking at the impact of the implementation of a cesarean risk calculator on cesarean delivery and maternal morbidity rates.

Study Overview

Status

Active, not recruiting

Conditions

Intervention / Treatment

Detailed Description

In this study a cesarean risk calculator will be instituted as a part of standard of care in a randomized rollout at 14 labor and delivery clinical sites across 4 institutions. The leadership at all of the sites have planned to implement this intervention for routine use at both sites. This study will evaluate cesarean delivery rates and maternal morbidity before and after implementation at each site.

Study Type

Interventional

Enrollment (Estimated)

20000

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Michigan
      • Ann Arbor, Michigan, United States, 48109
        • University of Michigan
      • Clinton Township, Michigan, United States, 48038
        • Henry Ford Macomb Hospital
      • Detroit, Michigan, United States, 48202
        • Henry Ford Hospital
      • Lansing, Michigan, United States, 48912
        • E.W. Sparrow Hospital
    • New Jersey
      • Plainsboro, New Jersey, United States, 08536
        • Princeton Medical Center
    • Ohio
      • Akron, Ohio, United States, 44307
        • Akron General
      • Cleveland, Ohio, United States, 44111
        • Fairview Hospital
      • Mayfield Heights, Ohio, United States, 44124
        • Hillcrest Hospital
    • Pennsylvania
      • Lancaster, Pennsylvania, United States, 17602
        • Lancaster General Health
      • West Chester, Pennsylvania, United States, 19380
        • Chester County Hosptial
    • Utah
      • Logan, Utah, United States, 84341
        • Logan Regional Hospital-Intermountain Healthcare
      • Ogden, Utah, United States, 84403
        • McKay-Dee Hospital
      • Riverton, Utah, United States, 84065
        • Riverton Hospital-Intermountain Healthcare
      • Salt Lake City, Utah, United States, 84132
        • University of Utah Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Study Population

See eligibility criteria above.

Description

Inclusion Criteria:

All postpartum patients who were eligible for cesarean risk calculator utilization:

  • delivery of a full-term (greater than or equal to 37 weeks) singleton gestation after presenting
  • with intact membranes
  • undergoing an induction of labor from cervical dilation less than or equal to 2cm

Exclusion Criteria:

Postpartum patient who had a prior pregnancy resulting in Cesarean delivery

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Non-Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Pre-utilization of cesarean risk calculator
The time prior to the implementation of the cesarean risk calculator at the labor and delivery unit.
Active Comparator: Implementation of cesarean risk calculator
The cesarean risk calculator will be incorporated into routine care at the site
The cesarean risk calculator will be incorporated into routine care at the site

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cesarean delivery rate (for any indication)
Time Frame: at time of delivery
at time of delivery
Maternal morbidity
Time Frame: from delivery to 30 days postpartum
one or more of the following: endometritis, postpartum hemorrhage greater than or equal to one liter, wound infection requiring antibiotics, venous thromboembolism, hysterectomy, intensive care unit admission, readmission within 30 days, and death
from delivery to 30 days postpartum

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Neonatal morbidity
Time Frame: delivery admission
one or more of the following: severe respiratory distress, neonatal resuscitation outside of delivery room, and sepsis
delivery admission

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Rebecca Hamm, MD, University of Pennsylvania

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2024

Primary Completion (Estimated)

September 1, 2027

Study Completion (Estimated)

September 1, 2027

Study Registration Dates

First Submitted

June 25, 2024

First Submitted That Met QC Criteria

July 3, 2024

First Posted (Actual)

July 5, 2024

Study Record Updates

Last Update Posted (Estimated)

September 10, 2025

Last Update Submitted That Met QC Criteria

September 2, 2025

Last Verified

September 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • 854955

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cesarean Delivery

Clinical Trials on Cesarean Risk Calculator

Subscribe